JESSICA ADAIR: Open Payments
NPI 1467793224 · MONTGOMERY, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,155 in 114 payments from 18 companies in 2025. Trend: 2023 $2,968 · 2024 $2,044 · 2025 $2,155
Food & beverage: $2,100Education: $55
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 24 | $579 |
| Boston Scientific Corporation | 31 | $339 |
| Novartis Pharmaceuticals Corporation | 10 | $220 |
| PFIZER INC. | 10 | $205 |
| Axsome Therapeutics, Inc. | 11 | $203 |
| Neurocrine BioSciences, Inc. | 7 | $147 |
| JAZZ PHARMACEUTICALS INC. | 2 | $81 |
| Amgen Inc. | 3 | $66 |
| ACADIA Pharmaceuticals Inc | 3 | $60 |
| EMD Serono, Inc. | 3 | $58 |
Products named: QULIPTA, KESIMPTA, Infinion 16, NURTEC ODT, INGREZZA, UBRELVY, Symbravo, Sunosi.
Industry payments across AL — which companies pay providers there.
